Nicolas Dano - Mediantechn Chief Unit

ALMDT Stock  EUR 3.48  0.07  2.05%   

Insider

Nicolas Dano is Chief Unit of Mediantechn
Phone33 4 93 33 37 77
Webhttps://www.mediantechnologies.com

Mediantechn Management Efficiency

The company has return on total asset (ROA) of (0.2475) % which means that it has lost $0.2475 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (5.1128) %, meaning that it generated substantial loss on money invested by shareholders. Mediantechn's management efficiency ratios could be used to measure how well Mediantechn manages its routine affairs as well as how well it operates its assets and liabilities.
Mediantechn has accumulated 16.4 M in total debt. Mediantechn has a current ratio of 2.05, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Mediantechn until it has trouble settling it off, either with new capital or with free cash flow. So, Mediantechn's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mediantechn sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mediantechn to invest in growth at high rates of return. When we think about Mediantechn's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

JeanPascal PharmDOSE Pharma SA
N/A
Jacques MartinEurobio Scientific SA
N/A
Herve MBAEurobio Scientific SA
64
Louis TannyeresKalray SA
65
Alain MDOSE Pharma SA
N/A
JeanMichel GrandmouginEurobio Scientific SA
62
Denis FortierEurobio Scientific SA
55
Thomas LamyBiosynex
N/A
Thomas IffEurobio Scientific SA
N/A
Erwan MenardKalray SA
N/A
Brangre VasseurOSE Pharma SA
N/A
Benot DinechinKalray SA
N/A
Dominique MDOSE Pharma SA
68
Silvia MDOSE Pharma SA
N/A
Linda MScOSE Pharma SA
56
Median Technologies SA develops and markets software products and platforms for medical image analysis in France and internationally. The company was founded in 2002 and is based in Valbonne, France. MEDIANTECHNOLOGIES operates under Diagnostics Research classification in France and is traded on Paris Stock Exchange. It employs 78 people. Mediantechn (ALMDT) is traded on Euronext Paris in France and employs 191 people.

Management Performance

Mediantechn Leadership Team

Elected by the shareholders, the Mediantechn's board of directors comprises two types of representatives: Mediantechn inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mediantechn. The board's role is to monitor Mediantechn's management team and ensure that shareholders' interests are well served. Mediantechn's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mediantechn's outside directors are responsible for providing unbiased perspectives on the board's policies.
Fredrik Brag, Co-Founder, Chairman, CEO and Pres
MD MS, Chief Officer
JeanChristophe Montigny, Chief Officer
Takashi Hayashi, Managing Japan
Bill Broderick, VP Services
Ciaran Cooper, Clinical Devel
Nicolas Dano, Chief Unit
Sophie Campagno, Chief Services
Marjorie Kooman, VP Relations
Emmanuelle Leygues, Head Communications

Mediantechn Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mediantechn a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Mediantechn Stock Analysis

When running Mediantechn's price analysis, check to measure Mediantechn's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mediantechn is operating at the current time. Most of Mediantechn's value examination focuses on studying past and present price action to predict the probability of Mediantechn's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mediantechn's price. Additionally, you may evaluate how the addition of Mediantechn to your portfolios can decrease your overall portfolio volatility.